Find link

language:

Find link is a tool written by Edward Betts.

searching for Cetuximab 33 found (433 total)

alternate case: cetuximab

Samuel D. Waksal (1,400 words) [view diff] exact match in snippet view article find links to article

At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with the Food and Drug Administration

Integrin alpha V (767 words) [view diff] exact match in snippet view article find links to article

Cutsem E, et al. (January 2015). "Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type

Ectropion (220 words) [view diff] exact match in snippet view article find links to article

Allergic Facial nerve palsy Anti-cancer treatments such as erlotinib, cetuximab, and panitumumab, which block the function of EGFR (the epidermal growth

Cytokine-induced killer cell (2,276 words) [view diff] exact match in snippet view article find links to article

it has been demonstrated the efficacy of a combined approach (CIK + Cetuximab) against triple negative breast cancer (TNBC), an aggressive tumor that

Biotechnology in India (1,377 words) [view diff] exact match in snippet view article find links to article

1?". Business Today. Retrieved 10 August 2023. "Alkem launches first cetuximab similar biologic in India". Generics and Biosimilars Initiative. 13 June

Roy S. Herbst (1,334 words) [view diff] exact match in snippet view article find links to article

II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of

Urelumab (1,121 words) [view diff] exact match in snippet view article find links to article

(NCT00461110), ipilimumab (NCT00803374), rituximab (NCT01775631, NCT02420938), cetuximab (NCT02110082), and elotuzumab (NCT02252263), nivolumab (NCT02253992) for

Isogenic human disease models (2,046 words) [view diff] exact match in snippet view article find links to article

(December 2008). "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer". J. Clin. Oncol. 26 (35): 5705–12. doi:10

Recombinant AAV mediated genome engineering (2,673 words) [view diff] exact match in snippet view article find links to article

(December 2008). "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer". J. Clin. Oncol. 26 (35): 5705–12. doi:10

Combined small-cell lung carcinoma (5,841 words) [view diff] exact match in snippet view article find links to article

tyrosine kinase inhibitors (TKIs): Erlotinib (Tarceva) Gefitinib (Iressa) Cetuximab (Erbitux) Inhibitors of vascular endothelial growth factor (VEGF) Bevacizumab

Immunohistochemistry (3,561 words) [view diff] exact match in snippet view article find links to article

patients who may benefit from therapeutic antibodies such as Erbitux (cetuximab). Commercial systems to detect epidermal growth factor receptor by immunohistochemistry

Combined small-cell lung carcinoma (5,841 words) [view diff] exact match in snippet view article find links to article

tyrosine kinase inhibitors (TKIs): Erlotinib (Tarceva) Gefitinib (Iressa) Cetuximab (Erbitux) Inhibitors of vascular endothelial growth factor (VEGF) Bevacizumab

Cross-reactive carbohydrate determinants (772 words) [view diff] exact match in snippet view article find links to article

Platts-Mills, T.A.; Commins, S.P. (2014). "Drug allergens and food--the cetuximab and galactose-α-1,3-galactose story". Ann. Allergy Asthma Immunol. 112

Let-7 microRNA precursor (8,221 words) [view diff] exact match in snippet view article find links to article

wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy". Annals of Oncology. 22 (1): 104–109. doi:10.1093/annonc/mdq315

Motolimod (302 words) [view diff] exact match in snippet view article find links to article

"Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck:

Chemotherapy regimen (634 words) [view diff] exact match in snippet view article find links to article

Dalesio O, Punt CJ (February 2009). "Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer". N Engl J Med. 360 (6): 563–72. doi:10

Alberto Bardelli (1,535 words) [view diff] exact match in snippet view article find links to article

Montagut, Clara (2016-02-03). "MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain

Patrick J. Loehrer (830 words) [view diff] exact match in snippet view article find links to article

; Kopit, Justin; Mayer, Robert J. (1 April 2004). "Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal

Sandro Porceddu (730 words) [view diff] exact match in snippet view article find links to article

S2CID 34975490. D I Pryor (2011). "Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma". Oral Oncol

Gedatolisib (855 words) [view diff] exact match in snippet view article find links to article

trial number NCT01925274 for "A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal

Phosphoinositide 3-kinase inhibitor (5,359 words) [view diff] exact match in snippet view article find links to article

ClinicalTrials.gov Clinical trial number NCT04495621 for "MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)" at ClinicalTrials.gov

Barbara Burtness (690 words) [view diff] exact match in snippet view article find links to article

recognition of her study "Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma

Waun Ki Hong (1,792 words) [view diff] exact match in snippet view article find links to article

El-Naggar AK, Garden AS, Papadimitrakopoulou V. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results

DAHANCA (1,112 words) [view diff] exact match in snippet view article find links to article

study of paclitaxel and capecitabine versus paclitaxel, capecitabine and Cetuximab as first line treatment for recurrent and or metastatic head and neck

DAHANCA (1,112 words) [view diff] exact match in snippet view article find links to article

study of paclitaxel and capecitabine versus paclitaxel, capecitabine and Cetuximab as first line treatment for recurrent and or metastatic head and neck

Waun Ki Hong (1,792 words) [view diff] exact match in snippet view article find links to article

El-Naggar AK, Garden AS, Papadimitrakopoulou V. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results

MM-151 (1,208 words) [view diff] exact match in snippet view article find links to article

bio-markers for EGFR pathways. MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain

Dendrimer (6,905 words) [view diff] exact match in snippet view article find links to article

boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron

Relda Marie Cailleau (1,654 words) [view diff] exact match in snippet view article find links to article

crucial for the discovery of EGFR related therapies such as antibodies like Cetuximab and kinase inhibitors such as Gefitinib currently used in treatment of

Tonsil carcinoma (2,455 words) [view diff] exact match in snippet view article find links to article

metastasis, hence showing poor prognosis. The treatment includes chemotherapy, cetuximab or both. Radiation may be used to aid in relieving symptoms arising from

Nabil F. Saba (1,710 words) [view diff] exact match in snippet view article find links to article

Saba NF (November 2021). "Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)"

Polysomy (4,281 words) [view diff] exact match in snippet view article find links to article

situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients". Clinical Cancer

Bing Li (academic) (2,443 words) [view diff] exact match in snippet view article

growth factor mAb Avastin and anti-epidermal growth factor receptor mAb cetuximab for treatment of human lung cancer and metastatic colorectal cancer, respectively